Coeptis Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Coeptis Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2022.
  • Coeptis Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$5.57M, a 19.9% increase year-over-year.
  • Coeptis Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$34.1M, a 190% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$14.2M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$34.1M -$5.57M +$1.38M +19.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$35.5M -$9.81M -$7.19M -274% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 -$28.3M -$15.8M -$14.1M -828% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$14.2M -$2.96M -$2.47M -508% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 -$11.8M -$6.95M -$5.34M -332% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$6.42M -$2.62M -$1.94M -282% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$4.48M -$1.7M -$1.3M -329% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$3.18M -$487K -$487K Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-11
Q3 2020 -$2.69M -$1.61M -$1.61M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.08M -$687K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$396K Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
Q4 2019 $0 Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-11
Q3 2019 $0 Jun 1, 2019 Aug 31, 2019 10-Q/A 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.